Enter your keyword


Promis DX

Promis Diagnostics was founded with the vision of enabling patients to lead healthier lives by providing actionable and affordable options for cancer screening. Using a highly specific custom detection method in combination with strong performance biomarkers, we aim to offer effective noninvasive options for colorectal cancer screening.


Cancer screening

DNA methylation

Aberrant methylation can inactivate tumor suppressors and DNA repair genes and it has been demonstrated to be an early event in the development of human cancers. Thus, DNA methylation changes in tumor tissues and body fluids such as blood, stool, sputum or urine have emerged as a highly promising biomarker for cancer screening.